Marilyn Hartogh v. HHS - Influenza, Guillain-Barré Syndrome (GBS) (2023)

Marilyn Hartogh filed a petition for compensation under the National Vaccine Injury Compensation Program on May 11, 2022, alleging she suffered Guillain-Barré Syndrome (GBS) after receiving an influenza vaccine on September 16, 2019. She claimed her GBS met the Table definition and resulted in residual effects for more than six months.

The respondent filed a Rule 4(c) report conceding entitlement, stating that the petitioner suffered GBS following a flu vaccine within the Table time period and that there was no evidence of an unrelated cause. Based on the respondent's concession and the record, a ruling on entitlement was issued on January 10, 2023, finding Ms.

Hartogh entitled to compensation. Subsequently, on March 20, 2023, the respondent submitted a proffer recommending an award of $175,000.00 for pain and suffering, which the petitioner agreed to.

The decision dated April 20, 2023, awarded Ms. Hartogh a lump sum payment of $175,000.00 for pain and suffering.